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Abstract. BS I1 lectin, a second hemagglutinin isolated from Bandeiraea SimpIicifolia seeds, 
agglutinated the red cells from 11 patients manifesting the ‘acquired B’ antigen phenomenon. 
The results of serological studies indicate that this lectin has specificity for the type I11 poly- 
agglutinable receptors rather than foy the ‘B-like’ antigens present on ‘acquired By red cells. 
Two other blood samples which did not possess ‘acquired B’ antigens were also found to 
react with BS I1 lectin. Both of these samples were shown to have properties similar to those 
reported for Tk red cells. The serological characteristics of red cells modified in vitro by a 
culture broth of Bacteroides f ragih  suggest that type I11 polyagglutinable receptors are identical 
to those associated with Tk red cells. 
Introduction 
Makela and Makela [9] reported anti-B 
hemagglutinating activity in saline extracts 
of Bandeiraea simplicifolia seeds. Hayes and 
Goldstein [4]  isolated from these seeds an 
a-D-galactosyl binding lectin, BS I, having 
a high affinity for group B red blood cells 
[8]. Zyer et al. [6] have now isolated a fur- 
ther lectin from B. simplicifolia seeds, desig- 
nated BSI  (GlcNAc lectin), which has a 
primary specificity for N-acetyl-D-glucos- 
amine. 
In serological tests BSII lectin failed to 
react with a large number of donor blood 
samples having normal ABO phenotypes, 
but did agglutinate the red cells from 11 
‘acquired B’ blood samples as well as those 
from 2 patients who had not acquired ‘B- 
like’ antigens. Bacteroides fragilis was isolat- 
ed by blood culture from one of these pa- 
tients. 
B. fragilis has recently been implicated in 
inducing Tk red cell polyagglutination [ 5 ] .  
We have studied red cells modified by this 
organism in vitro. Our results indicate that 
the type I11 polyagglutinable receptors pre- 
sent on ‘acquired B’ red cells [ 11 are identi- 
cal to those that define Tk polyagglutina- 
tion. 
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Materials and Methods 
BS I1 lectin was isolated from B. simplicifolia 
seeds by affinity chromatography on chitin as 
previously described [6] and diluted to an initial 
concentration of 0.4 mg/ml with 22% bovine 
albumin. Bovine albumin was also used as the 
diluent in titration studies. Agglutination tests 
were performed by adding l v o l  of a 5% saline 
suspension of washed red cells to  2vol of lectin. 
Following incubation at 4 OC for 1 h the tests were 
centrifuged at 1,ooOg for 15sec and examined 
macroscopically. Agglutination reactions were 
scored according to the method of Race and 
Sanger [lo]. Sugar inhibition studies were carried 
out with 0.1 M solutions of the various sugars in 
phosphate-buffered saline at pH 7.3. Details of 
other serological techniques have been presented 
elsewhere [7]. 
Table I. Reactions of ‘normal’ and selected red cell 
phenotypes with BS I1 lectin 
Weakly reactive (titer 2, score 8)  
Protease-treated (all ABO types) 
Neuraminadase-treated (all ABO types) 
Tn(3), Cad 2(2) 
Strongly reactive (titer 32, score 47) 
‘Acquired B ’ red cells(1) 
Figures in parentheses indicate the number of 
each cell type tested. 
Results 
Serological Specificity of BS ZZ Lectin 
BS I1 lectin did not agglutinate the red 
cells from 48 group 0, 52 group A,, 18 
group A,, 36 group B or 43 group AB donor 
blood samples. Red cells with uncommon 
phenotypes within the ABO, P, MNSs and 
rhesus blood group systems were also non- 
reactive. Weak reactions (titer 2, score 8) 
were encountered with protease or neur- 
aminidase (Vibriu cho1erue)-treated red cells, 
as well as with the polyagglutinable red cell 
types Tn and Cad2. A blood sample from 
a patient having acquired ‘B-like’ antigens 
was found to be strongly reactive with BS I1 
lectin. These results are summarized in ta- 
ble I. 
10 further examples of ‘acquired B’ red 
cells were tested with BS I1 lectin. Although 
initially only 4 reacted, all did so following 
ficin treatment (table 11). No such enhance- 
ment was observed following ficin treat- 
ment of normal, Tn, Cad2 or neuramini- 
dase-treated (T-activated) red cells. 
An additional 236 blood samples sub- 
mitted to the blood bank were tested, and 
the red cells from 2 patients, Mrs. L (group 
A,) and Mrs. M (group B), were strongly 
agglutinated by BS I1 lectin. Although these 
red cells had not acquired ‘B-like’ antigens 
they were polyagglutinable. B. frugilis was 
isolated from a blood culture of Mrs. M. 
Studies on B. frugilis-Modified 
Red Cells 
Normal red cells were modified with the 
supernatant from the blood culture obtained 
from Mrs. M, and tested with BS I1 and 
Aruchis hypogoeu lectins. The results of 
these tests are shown in table 111. The modi- 
fied red cells reacted strongly with BS I1 
lectin and weakly with A. hypoguea. Treat- 
ment of the modified red cells with ficin 
resulted in marked ‘enhancement of aggluti- 
nation by both reagents, in contrast to the 
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Table II. Reactions of eleven examples of ‘acquired B’ red cells with BS I1 lectin 
Case No. 
1 2  3 4  5 6 7 8  9 10 11 A B 
~ ~ ~~ 
Untreated 
Titer 16 0 16 0 8 3 2 0 0  8 0 0 0  0 
Score 3 2 0  34 0 31 47 0 0 20 0 0 0  0 
Ficinized 
Titer 512 32 512 8 256 512 8 4 128 8 16 2 2 
Score 98 42 96 24 82 100 21 18 76 31 32 8 8 
Table III. Results of titration studies on ‘acquired By red cells and red cells modified by B. frugilis with BS I1 
and A. hypogoea lectins 
BS-2 lectin A. hypogoea 









































































Tests performed at 4°C for 1 h. BF=Cells treated with B. fragilis culture broth. 
a Neuraminidase-treated. 
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results obtained following ficin treatment 
of neuraminidase-treated (T-activated) red 
cells. 
The results of tests with BS I1 lectin and 
A. hypogoea on the red cells from Mrs. L 
and Mrs. M are also shown in table 111. 
Ficin treatment of these cells resulted in 
enhancement of agglutination, similar to 
that observed following ficin treatment of 
the B. fragilis-modified red cells. 
The red cells of Mrs. L, Mrs. M and red 
cells modified in vitro by the B. frugilis 
culture broth were shown to have properties 
similar to those reported for Tk red cells [5] .  
Agglutination in group AB serum was en- 
hanced by ficin. There was no agglutination 
in A. hypogoeu which had been absorbed 
with neuraminidase-treated red cells. Aggre- 
gation in Polybrene was normal. The sera 
of Mrs. L and Mrs. M contained normal 
quantities of anti-T. 
Group A, red cells were treated with the 
B. fragilis culture broth and tested by ab- 
sorption and elution techniques with group 
A sera and commercial anti-B reagents. No 
evidence for the acquisition of ‘B-like’ anti- 
gens could be demonstrated on these modi- 
fied red cells. 
Demonstration of Tk Receptor on 
‘Acquired B’ Red Cells 
Table I11 also shows the results of tests 
with A. hypogoeu on the red cells from 5 
‘acquired B’ blood samples. All were weakly 
agglutinated by A.  hypogoea, and the reac- 
tions were enhanced by ficin. Agglutination 
of these ‘acquired B’ samples in group AB 
serum was also enhanced by ficin, and the 
red cells from each case were found to ag- 
gregate in Polybrene. Absorption of group 
AB serum with red cells modified by the 
B. fragilis culture broth completely removed 
its activity for all five samples. The sera 
from these ‘acquired By bloods contained 
anti-T. 
Inhibition Studies on BS I I  Lectin 
The extent to which various sugars inhi- 
bited the hemagglutinating activity of BS I1 
lectin was studies. N-acetyl-D-glucosamine 
inhibited the agglutination of all reactive 
red cell samples, including those modified 
by B. fragilis in vitro. 
No inhibition was observed with lactose, 
D-galactose, D-glucose, N-acetyl-D-man- 
nosamine or with N-acetyl-D-galactosamine. 
Saliva samples (secretor and non-secretor), 
purified A and B substances, and hydatid 
cyst fluids also were non-inhibitory. 
Discussion 
According to Gerbul et al. [3] the ‘ac- 
quired-B’ antigen phenomenon arises from 
the action of a deacetylase, produced by 
certain strains of Escherichia coli. This en- 
zyme transforms N-acetyl-D-galactosamine 
on group A, cells into D-galactosamine 
which cross-reacts with human anti43 rea- 
gents. It is evident, however, that BSII 
activity with ‘acquired By cells is not directly 
related to bacterial deacetylation for the 
following reasons. First, 2 patients’ blood 
samples, one of which was group A,, react- 
ed strongly with BS I1 lectin but did not 
exhibit the ‘acquired B’ antigen phenome- 
non. Second, the supernatant broth from a 
culture of B. fragilis did not transform A, 
red cells into ‘acquired B’ red cells, although 
these modified red cells reacted strongly 
with BS I1 lectin. Finally, BS I1 lectin is in- 
hibited by N-acetyl-D-glucosamine but not 
by N-acetyl-D-galactosamine or D-galactose, 
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the A and B immunodominant sugars, re- 
spectively. 
An enzyme produced by certain strains 
of B. fragilis has been implicated by Inglis 
et al. [5] in causing Tk polyagglutinability. 
We have demonstrated that BSII lectin 
reacts with red cells modified in vitro by 
the supernatant from a broth culture of this 
organism, and Bird [2] found that BSII 
lectin reacted with in-vivo-induced Tk red 
cells. It is therefore our contention that 
BS I1 lectin recognizes the Tk polyagglutin- 
able receptor. 
The results of studies on the poly- 
agglutinable red cells of Mrs. L, Mrs. M 
and the ‘acquired B’ blood samples indicate 
that these cells possess Tk receptors. Of 
particular significance is the observation 
that the agglutinins in group AB sera, which 
react with ‘acquired B’ red cells, are absorb- 
ed by red cells modified in vitro by B.  fru- 
gilis. 
Bird [2] also observed that BS I1 lectin 
reacts with red cells T-activated in vivo. 
This is especially significant since we were 
unable to demonstrate any appreciable activ- 
ity of BS I1 lectin for red cells modified by 
neuraminidase in vitro. This suggests that 
certain neuraminidase-producing organisms 
are capable of exposing the Tk receptor in 
vivo. An alternative explanation is that more 
than one enzyme, each of a different bacte- 
rial origin, acts simultaneously or sequential- 
ly to modify the red cell membrane in vivo. 
Thus, in certain group A, individuals a 
bacterial deacetylase produces the ‘acquired- 
B’ antigen, while another enzyme, possibly 
from B. fragilis, exposes the Tk receptor. In 
those group A patients whose red cells are 
not susceptible to the action of bacterial 
deacetylase, for reasons given by Gerbd et 
al. [3], and in group 0, B or AB in- 
dividuals, the B. frugilis enzyme alone pro- 
duces modification resulting in the exposure 
of Tk polyagglutinable receptors. 
Beck et ul. [l] proposed that the polyag- 
glutination observed with ‘acquired B’ red 
cells be termed ‘type 111’. In view of the sim- 
ilarity between the polyagglutinable prop- 
erties of both Tk and ‘acquired B’ red cells, 
we suggest that Tk polyagglutination be 
redesignated as type 111. 
The results of inhibition studies on BS I1 
lectin suggest that N-acetyl-D-glucosamine 
is involved in the structure of the Tk recep- 
tor. The nature of the B. fragilis enzyme 
remains ill-defined and is the subject of 
current study. 
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